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Spindle cell hemangioendothelioma (SCH) was originally described by Weiss and Enzinger (1986) as a low-grade angiosarcoma
resembling both cavernous hemangioma and Kaposi’s sarcoma. Recent studies suggest that SCH is a benign neoplasm or reactive
lesion accompanying a congenital or acquired vascular malformation. Most SCHs present as one or more nodules aﬀecting the
dermis or subcutis of the distal extremities. Few reports describe SCH of the head and neck region; even fewer note intramuscular
SCH. Here, we describe a case of SCH involving the temporal muscle mimicking soft tissue sarcoma, who had a successful surgical
treatment with a coronal approach and zygomatic osteotomy.
1.Introduction
Spindle cell hemangioendothelioma (SCH) was ﬁrst
described in 1986 by Weiss and Enzinger as a vascular
neoplasm, characterized by cavernous blood vessels and
spindled areas reminiscent of Kaposi’s sarcoma [1]. SCH
typically presents as a single tumor or multiple nodules
involving the dermis and subcutaneous tissues of the distal
extremities [2, 3]. The head and neck region is rarely
involved; only six cases have been previously reported [4].
Intramuscular SCH is considered extremely rare [5]. We
present a case of SCH arising in the temporal muscle that
resembles a malignant soft tissue tumor.
2. Case Presentation
A 67-year-old female complained about swelling of the left
temporal area with a 4-month history. She had no previous
history of trauma in the region. On examination, there
was a ﬁrm, hemispherical mass 40mm in diameter in the
temporal area; overlying skin appeared normal. The mass
was immobile against underlying bone. Trismus or facial
palsy was not observed (Figure 1).
Magnetic resonance imaging (MRI) revealed a relatively
well-demarcated mass in the left temporal muscle, which
showed low signal intensity on T1-weighted images and
high signal intensity admixed with irregular low signal
areas on T2-weighted images (Figure 2). Computed tomog-
raphy showed an ill-demarcated round mass. Heterogeneous
enhancement of the mass and adjacent temporal muscle
was observed between the coronoid process and temporal
fossa (Figure 3). A highly vascularized soft tissue tumor with
malignant potential was suspected based on the aggressive
features indicated by radiology and rapid growing of the
lesion.
An incisional biopsy was performed under general
anesthesia to evaluate histology. The specimen revealed pro-
liferation of dilated small vessels with hemorrhage associated
with inﬂammatory components. Abnormal mitotic ﬁgures
were not observed. Histological features suggested a benign2 Case Reports in Surgery
Figure 1: Preoperative view of the patient.
Figure 2: Preoperative MRI on T2-weighted image showing high
signal intensity admixed with irregular low signal areas in left
temporal fossa.
Figure 3: Preoperative contrast CT showing ill-demarcated low-
density mass with enhancement of the adjacent temporal muscle.
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Figure 4: Intraoperative view demonstrating intramuscular tumor
(arrows) with the assistance of zygomatic osteotomy (asterisks).
or intermediate vascular tumor, particularly angiolymphoid
hyperplasia with eosinophilia.
Surgical excision was performed under general anesthe-
sia. First, a hemicoronal incision of the scalp was made;
subsequently, the superﬁcial surface of the temporal muscle
and zygomatic arch were exposed. A solid nodule was
palpated in the temporal muscle and continued beneath
the zygomatic arch (Figure 4). Osteotomy of the zygomatic
arch was performed, and the bone fragment was temporarily
r e m o v e d .T h ee n t i r et e m p o r a lm u s c l ew a sb l u n t l yd i s s e c t e d
from adjacent bones, revealing no bony involvement. Then,
the temporal muscle was severed just distal to the coronoid
process and at the distal insertion, removing the tumor with
the muscle en bloc. Finally, the zygomatic arch fragment
was replaced and ﬁxed with 3/0 absorbable sutures. A
suction drain was inserted in the temporal fossa, and
the scalp wound was closed in two layers. The surgical
specimen showed thin-walled cavernous vessels lined by
endothelial cells, hemorrhage, and spindle-shaped cells with
inﬂammatory cell inﬁltration. Abnormal mitotic ﬁgures or
cellular atypia was not observed (Figures 5(a) and 5(b)).
These histological characteristics led to a diagnosis of SCH.
Postoperative course was uneventful. No signs of local
recurrence were observed during two years of followup.
Postoperative complications such as facial palsy, trismus, or
alopecia have not been observed. The patient was satisﬁed
with the aesthetic result, though a mild depression was
observed in the temporal area (Figure 6).Case Reports in Surgery 3
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(b)
Figure 5: Microscopic ﬁndings of the spindle cell hemangioen-
dothelioma. (a) Low-power view of the lesion showing cavernous
blood vessels ﬁlled partly or completely with erythrocytes or
thrombus admixed with cellular zones (hematoxylin-eosin, original
magniﬁcation ×40). (b) High-power view of juxtaposition of the
cavernous and cellular areas illustrating blood-ﬁlled dilated vessels
lined by ﬂattened endothelial cells and spindle-shaped cellular
components. There is no evidence of abnormal mitotic activity
or nuclear atypia in spindled cells (hematoxylin-eosin, original
magniﬁcation ×100).
3. Discussion
This case of SCH involving temporal muscle is extremely
rare. According to the 78 series of SCH reported by Perkins
and Weiss, four cases occurred in the head and neck region,
while 62 cases involved extremities [6]. To date, six cases
of SCH of the head and neck have been reported [4].
Because most SCHs present as nodules involving dermis and
subcutaneoustissue[2,3],fewreportsexistonintramuscular
SCH [5]. Recent studies classify SCH as a reactive lesion
that arises in association with a local congenital or acquired
vascular malformation, rather than a neoplastic lesion [7–
9]. In the present case, pathogenesis of temporal muscle
involvement remains unclear given that angiography was not
performed preoperatively. However, contrast CT revealed
high vascularity of the entire temporal muscle, which
Figure 6: Postoperative view at 24 months followup.
may indicate that the SCH was associated with vascular
abnormalities in the muscle.
Local recurrence is prevalent in SCH. Of the reports
by Perkins and Weiss, 58 percent of patients developed
recurrences in the same general area of the body [6].
Because of such high rate of recurrence, SCH was originally
considered a low-grade angiosarcoma [1]. However, recent
evidence indicates that the majority of lesions are partially
or exclusively intravascular [6]. Therefore, “recurrence” is
deﬁned as contiguous or multifocal spreading of the lesion
along an aﬀected vessel [6, 7, 10]. Overall, prognosis is
excellent and no metastases from SCH have been reported
to date [6]. However, considering the location of the SCH
occupying the temporal and infratemporal fossa in the
present case and since SCH can be associated with vascular
abnormalities, marginal excision carried the risk of local
“recurrence” and massive blood loss. Thus, we performed
en bloc excision of the entire aﬀected muscle [5]w i t h
a coronal approach and zygomatic osteotomy. The intra-
and postoperative course was uneventful, with satisfactory
aesthetic results and no evidence of recurrence. Further
followup may be required.
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